Mulkey Laboratory
HOME / Developing Brain Institute
The Mulkey Laboratory, led by Sarah B. Mulkey, M.D., Ph.D., focuses on the neurological implications of a range of infectious diseases that can be transmitted from mother to fetus during pregnancy. Dr. Mulkey has contributed prenatal and neonatal neurology expertise to one of the nation’s first comprehensive Zika specialty programs. In addition, she serves as Co-Director of the Congenital Infection Program, which provides expertise to diagnose, manage and conduct research related to congenital infections, such as Zika virus, Cytomegalovirus, HSV, COVID, Toxoplasmosis, Lyme disease and Chagas disease.
Lab Focus Area
Congenital Infection Program
Diagnosing, managing and conducting research related to congenital infections
Zika virus
Studying long-term impacts for infants exposed to Zika during pregnancy
Lyme Disease in Pregnancy
Helping families affected by tick-borne diseases, including Lyme disease
Our Research
The Mulkey Lab is committed to studying long-term neurodevelopmental impacts for infants born to mothers infected during pregnancy through research conducted domestically and internationally, in collaboration with colleagues in Colombia.
